Status:
COMPLETED
Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype
Lead Sponsor:
Edimer Pharmaceuticals
Collaborating Sponsors:
National Foundation of Ectodermal Dysplasia
Conditions:
Hypohidrotic Ectodermal Dysplasia
X-Linked Hypohidrotic Ectodermal Dysplasia
Eligibility:
All Genders
Brief Summary
This study is being done to collect information about people who have or may have Hypohidrotic Ectodermal Dysplasia (HED) or X-linked Hypohidrotic Ectodermal Dysplasia (XLHED). This study will allow E...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Males or females with:
- the clinical characteristics of HED, including at least two of the following characteristics: a history of decreased sweating;abnormal teeth (fewer permanent teeth, teeth are smaller than average and often have conical crowns);sparseness of scalp and body hair.
- OR-
- genetically confirmed HED or XLHED;
Exclusion
Key Trial Info
Start Date :
April 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT01398397
Start Date
April 1 2011
Last Update
June 28 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Edimer Pharmaceuticals
Cambridge, Massachusetts, United States, 02142